Company Overview of Ascletis, Inc.
Ascletis, Inc., a specialty therapeutics company, discovers and develops treatments for cancer and infectious diseases. It provides ALN-VSP, a therapeutic comprising of siRNAs designed to target genes critical for the growth and development of cancer cells. The company has strategic partnerships with Alnylam Pharmaceuticals, Inc.; and Minsheng Pharma. Ascletis, Inc. was founded in 2011 and is based in Chapel Hill, North Carolina with operation sites in Hangzhou, China; and Research Triangle Park, North Carolina.
1002 Northridge Lane
Chapel Hill, NC 27514
Founded in 2011
Key Executives for Ascletis, Inc.
Ascletis, Inc. Key Developments
Similar Private Companies By Industry
|Alva-Amco Pharmacal Companies, Inc.||United States|
|Theracos, Inc.||United States|
|Alliance Pharmaceutical Corp.||United States|
|Ion Laboratories, Inc.||United States|
|SynGlyco, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ascletis, Inc., please visit www.ascletis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.